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Saffold virus is able to productively infect primate and
rodent cell lines and induces apoptosis in these cells
Yishi Xu1,2, Carla Bianca Luena Victorio1,2, Qimei Ng1, Yee Joo Tan2,3 and Kaw Bing Chua1
Saffold virus (SAFV), a newly discovered human cardiovirus of the Picornaviridae family, causes widespread infection among children,
as shown by previous seroprevalence studies. To determine the host cell range of SAFV and its cytopathogenicity, eight
mammalian cell lines that were available in the laboratory were screened for productive SAFV infection by a laboratory-adapted SAFV of
genotype 3. Five of the cell lines (Neuro2A, CHO-K1, NIH/3T3, Vero and HEp-2) were found to be permissible. The time required
for SAFV to induce complete lysis as a cytopathic effect (CPE) in these permissibly infected cells and the resultant end point virus titer
differed for each cell type. HEp-2 exhibited the shortest time frame to reach full CPE compared to the others. All infected cell
lines produced a high virus titer at 72 h post-infection. In addition to causing lytic cell death, SAFV also induced apoptotic cell death in
host cells through both extrinsic and intrinsic pathways, although the apoptotic events in HEp-2 cells appeared to have been blocked
between the early and late stages. In conclusion, laboratory-adapted SAFV is able to productively infect a number of mammalian
cell lines and induce apoptosis in the infected host cells. However, apoptosis in HEp-2 cells is blocked before the end stage.
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INTRODUCTION
Saffold virus (SAFV) is a member of the Theilovirus species in the
Cardiovirus genus of the family Picornaviridae.1–3 The virus was ini-
tially named human Theiler’s-like cardiovirus due to its close phylo-
genetic relation to Theiler’s murine encephalomyelitis virus (TMEV).4
Similar to other cardioviruses, SAFV is a non-enveloped single-
stranded RNA virus of positive polarity. The genome of SAFV is
8050 nucleotides (nt) long and, similar to other cardioviruses, has
one open reading frame with 13 cleavage sites, from which 12 separate
proteins are derived: L, VP4, VP3, VP2, VP1, 2A, 2B, 2C, 3A, 3B, 3C
and 3D.5 The 59 untranslated region contains a type II internal ribo-
somal entry site that is 1040 nt long.6 The 39 untranslated region,
which contains the poly(A) tract, is approximately 120 nt long.
Phylogenetic analysis of SAFV revealed that SAFV is genetically most
closely related to Theiler-like rat virus and TMEV.5
Prior to the discovery of SAFV, viruses belonging to the Cardiovirus
genus were only known to infect animals. The human origin of
Vilyuisk virus, another cardiovirus, was equivocal, and the virus was
suspected to be a recombinant form of human and murine cardio-
viruses resulting frommultiple passages in themouse brain during the
process of its isolation.7,8 SAFV was first isolated in 1981 from a stool
sample of an 8-month-old girl presenting with fever of unknown
origin, but it was only characterized and reported much later, in
May 2007.5 A year later, Abed and Boivin9 reported the isolation of
a genotype 2 SAFV (SAFV-2) from three Canadian children exhibiting
respiratory symptoms. Drexler et al.10 reported the detection of SAFV-
3 from patients with acute enteritis in Germany and Brazil.
Subsequently, Zoll et al. described the first cell-cultivatable SAFV-3
isolated from a stool sample of a 13-month-old boy in the
Netherlands.3 In the same year, five more genotypes of SAFV were
identified from stool specimens through the molecular detection of
cardiovirus infection among South Asian children.11 Recently, 11 gen-
otypes of SAFV were detected using consensus degenerate primers
targeted against the VP1 gene region, and their respective genetic
sequences were deposited in the NCBI GenBank. Furthermore, a 3-
year prospectivemolecular epidemiological study inDenmark showed
that three phylogenetically distinct lineages of SAFV-2 were intro-
duced into the country and remained in cocirculation.12
The distribution of SAFV is most likely widespread, based on
published data of its frequent molecular detection and the available,
albeit limited, seroprevalence studies. Zoll et al.3 showed that SAFV-3
infection occurs early in life and can reach infection rates of more than
90% in children older than 24months based on a seroprevalence study
conducted in several countries in Europe, Africa and Asia. A seropre-
valence study of SAFV infection conducted in the Netherlands,
Finland, Cameroon and Indonesia showed that the seroprevalence
of SAFV-2 was similar to that of SAFV-3.13 A similar trend of a high
seroprevalence of SAFV-3 was also found in Malaysia, where 67.5%–
75% of serum samples collected from 10- to 12-year-old children
from various Malaysian states were seropositive.14 However, the rela-
tionship between SAFV infection and actual disease in humans
remains equivocal, although the virus was recently reported to have
been isolated from the cerebrospinal fluid of a child with aseptic
meningitis.15
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TMEV, which is a Theilovirus species, as is SAFV, has been shown to
induce apoptosis in macrophages and necrosis in rodent cells.16
Apoptosis is an active process of programmed cell death that occurs
as a part of normal development and aging. It can also be induced by
various stimuli as an immune defense mechanism against pathogenic
or noxious agents.17 Whether a cell dies by apoptosis depends on
several conditions such as the nature of the cell death signal and the
cell type.18,19 Previously, it was shown by Chua et al.14 that HEp-2 cells
infected by SAFV-Penang exhibited cytopathic effects (CPE) sugges-
tive of cells undergoing apoptosis. However, apoptosis induced by
SAFV infection remains to be demonstrated.
There are two main mechanisms through which apoptosis is
induced in cells, namely, the extrinsic and intrinsic pathways. In the
extrinsic pathway, death-inducing ligands outside the cell bind to
specific transmembrane death receptors and lead to the formation
of a death-inducing signaling complex, which in turn activates cas-
pase-8 and eventually caspase-3.20 The intrinsic pathway is initiated by
changes in the inner mitochondrial membrane, which cause the open-
ing of the mitochondrial permeability transition pore, disruption of
mitochondrial transmembrane potential and release of cytochrome C
into the cytosol.21 Cytochrome C binds and activates Apaf-1 and
caspase-9 by forming an ‘apoptosome’, and this eventually activates
caspase-3.22–24
Understanding the interaction between a virus and cells of various
provenances is crucial for the elucidation of virus infection mechan-
isms and pathogenesis, as well as for the prediction of the potential
host range of a virus. In addition, information on the cytopathogeni-
city of this newly discovered human cardiovirus is grossly lacking due
to the poor ability of previous clinical isolates to productively infect in
vitro cultured cells. In this study, (i) we focus on the types of cells that
are permissible to productive SAFV infection; (ii) the effect of SAFV
infection on host cells; and (iii) the forms of cell death resulting from
infection.
MATERIALS AND METHODS
Antibodies, cell lines and virus
The following antibodies used in this study were purchased commer-
cially: rabbit anti-caspase-8 was purchased from R&D Systems
(Minneapolis, MN, USA); mouse anti-caspase-9, rabbit anti-cas-
pase-3 and rabbit anti-actin antibodies were from Cell Signaling
Technology (Beverly, MA, USA); rabbit anti-mouse immunoglobu-
lins-horseradish peroxidase and swine anti-rabbit immunoglobulins-
horseradish peroxidase were from Dako (Glostrup, Denmark).
The study was performed using cell lines that were available in the
laboratory and were previously obtained fromAmerican Type Culture
Collection. All the cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM;Gibco, Grand Island, NY, USA) supplemented with
10% fetal bovine serum (FBS; i-DNA, Singapore) and 0.22% (w/v)
sodium bicarbonate (NaHCO3; Sigma Aldrich, St Louis, MO, USA)
and incubated at 37 6C in 5% CO2. The cell lines used were originally
derived from human adenocarcinoma samples (HEp-2, CCL-23),
African greenmonkey kidneys (Vero, CCL-81),mouse neuroblastoma
(Neuro2A, CCL-131), mouse fibroblasts (NIH/3T3, CRL-1658),
mouse kidneys (TCMK, CCL-139), mouse macrophages (J774A.1,
TIB-67 and RAW 264.7, TIB-71) and hamster kidneys (CHO-K1,
CCL-61).
The SAFV (SAFV-Penang strain) used in this study belongs to
genotype 3 and was originally isolated in HEp-2 cells14 (Chua et al.,
GenBank accession NO HQ162476.1) before it was subsequently
adapted to Vero cells following eight continuous passages.
Assay for permissible cells and kinetics of cell death
Cells were seeded overnight at a density of 13106 cells per tissue
culture-treated T-25 cm2 flask or 53104 cells per well in 24-well
plates. Virus, at a multiplicity of infection of 10, was adsorbed onto
the cells for 2 h at 37 6C in 5% CO2 with gentle rocking every
20 min. The virus supernatant was subsequently removed, and
the cells were washed twice with sterile phosphate-buffered saline
(PBS) solution. Five milliliters of DMEM supplemented with 1%
FBS and 0.22% NaHCO3 were ultimately added into each flask, and
the inoculated cultures were incubated at 37 6C in 5% CO2. The
inoculated cells were observed by two independent observers every
6 h. The morphology of the cells corresponding to early, mid and
full CPE (approximately 10%, 50% and 100% CPE, respectively)
was captured using an Olympus IX71 inverted light microscope.
The times required for the respective infected cell lines to reach
early, mid and full CPE were also recorded. Both the detached and
adherent cells were separately harvested at various time points cor-
responding to the time of appearance of early, mid and full CPE.
The harvested cells were pooled and pelleted by centrifugation at
300g for 10 min. The cell pellet was resuspended and washed twice
with sterile PBS. After the last wash and centrifugation, cells were
resuspended in PBS or lysis buffer depending on the downstream
assay for evidence of apoptosis. The time at the point of virus
inoculation into the culture medium was designated as time zero,
and the experiment was repeated thrice.
Quantitation of virus titer and virus growth kinetics assay
NIH/3T3, Neuro-2A, Vero, HEp2 and CHO-K1 cells were seeded
overnight (53105 cells per well) in six-well culture plates and then
infected with 10 multiplicity of infection SAFV (100 mL per well) in
triplicate and incubated at 37 6C for 2 h. After 2 h of incubation, the
culture supernatant in each well was removed, and the adherent cells
were washed twice in sterile PBS, followed by the addition of fresh
maintenance medium (DMEM, 1% FBS). The culture plates were
incubated at 37 6C in 5% CO2. At 12-h intervals (0, 12, 24, 36, 48, 60
and 72 hours post-infection (hpi)), one plate was harvested and frozen
at280 6C. Plates were subjected to three freeze–thaw cycles, and lysates
were cleared by centrifugation at 1500g for 5 min prior to the deter-
mination of virus titers.
Cleared supernatants were subjected to end point titration using
Vero cells, and the virus titer was enumerated using the Reed and
Muench method.25 Briefly, Vero cells (43103 cells per well) were
seeded overnight in 96-well plates. Frozen supernatant containing
the virus was allowed to thaw to room temperature, followed by dilu-
tion (1021) in sterile 1% aqueous sodium deoxycholate (Sigma
Aldrich) and vigorously mixed for 15 min to disaggregate virus.
Disaggregated virus was subjected to 10-fold serial dilution in
maintenance medium (DMEM, 1% FBS) and 100 mL of the diluted
virus from the 1023 dilution onwards was added into eachwell of Vero
cells. Plates were incubated at 37 6C and observed daily under an
inverted light microscope for the appearance of distinct CPE. Virus
titer was reported as 50% cell culture-infectious doses per volume
(CCID50/mL) and calculated using the Reed and Muench
Calculator.25
Positive control of apoptosis
Staurosporine (STAU; Sigma Aldrich), a fungal metabolite, used as
positive control in the investigation of apoptosis induced by SAFV,
is known to induce apoptotic cell death in many types of mam-
malian cells through both the extrinsic and intrinsic pathways. Five
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milliliters of DMEM supplemented with 10% FBS containing
13106 cells of the respective permissible cell lines were added to
tissue culture-treated T-25 cm2 flasks. After overnight incubation,
1 mM of staurosporine was added to the culture media, and both
the detached and adherent cells were separately harvested following
another 4 h of incubation. The harvested cells were pooled together
and pelleted by centrifugation at 300g for 10 min. The cell pellet
was resuspended and washed twice with sterile PBS. After the last
wash and centrifugation, cells were resuspended in PBS or lysis
buffer, depending on the downstream application used to deter-
mine the presence of apoptosis.
DNA laddering assay
The pooled SAFV-infected or staurosporine-treated cells were sepa-
rately washed with PBS and treated with cell lysis buffer (1% NP-40 in
20mMEDTA, 50mMTris-HCl, pH 7.5) for 10 s. The supernatant was
collected following centrifugation, supplemented with 1% sodium
dodecyl sulfate (SDS) and treated with 5 mg/mL of RNase A for 2 h
at 56 6C. Subsequently, samples were incubated in 2.5 mg/mL of pro-
teinase K for 2 h at 37 6C, and then supplemented with 0.5 volume of
10 M ammonium acetate and 2.5 volumes of ice-cold ethanol.
Suspensions were incubated at 280 6C for 1 h and centrifuged for
20 min at 12 000 rpm. The pellet was washed with 80% ice-cold eth-
anol, air-dried at room temperature for 10 min and dissolved in Tris-
HCl/EDTA (TE) buffer. The quantity of DNA was measured via spec-
trophotometry and 4 mg of DNA was loaded into wells of 2% agarose
gel for electrophoresis run.26 The experiments involving the DNA
laddering assay were repeated independently three times.
Apo-ONE fluorometric assay
Only the infected cells harvested at mid CPE were used in the Apo-
ONE fluorometric assay to determine the presence of SAFV-induced
apoptosis. Both infected andmock-infected cell monolayers were har-
vested, as described earlier, and treatedwith RIPA buffer (0.5%NP-40,
0.5% deoxycholic sodium, 0.005% SDS in 50 mM Tris, pH 8.0,
250 mM NaCl) and Complete Protease Inhibitor (Roche Applied
Science, Singapore). The treated cells were then subjected to five
freeze–thaw cycles. Apoptotic activity due to caspase-3/7 activation
was subsequently measured using an Apo-ONE Fluorometric Assay
Kit (Promega Corporation, Madison, WI, USA) according to the
manufacturer’s protocol.
Western blot
The pooled harvested SAFV-infected or staurosporine-treated cells
were washed with PBS and treated with Complete Lysis-M and
Complete Protease Inhibitor (Roche Applied Science) for 5 min.
Protein samples (20 mg each) were electrophoresed in 16% SDS poly-
acrylamide gels and transferred onto polyvinylidene difluoride mem-
branes (Bio-Rad, Philadelphia, PA, USA). Membranes were blocked
for 1 h at room temperature in a suspension of 5% (w/v) blotting grade
non-fat milk dissolved in PBS supplemented with 1% Tween-20 (PBS-
T). Membranes were incubated overnight at 4 6C with the primary
antibody in PBS-T buffer supplemented with 5% non-fat milk. The
membranes were washed three times and subsequently incubated at
room temperature for 1 h with anti-mouse or anti-rabbit immunoglo-
bulins-horseradish peroxidase in 5% (w/v) non-fat milk in PBS-T. The
Western blotting experiments were independently repeated three
times.
Statistical analysis
A paired Student’s t-test was used in this study and differences were
considered statistically significant at P,0.05 and extremely significant
at P,0.01.
RESULTS
SAFV is able to infect primate and rodent cell lines and the kinetics
of cell death vary
Of the eight cell lines infected with laboratory-adapted SAFV, all
except TCMK, J774A.1 and RAW 264.7 (mouse cell lines) were
permissible to productive SAFV infection. The representative pat-
terns of early, mid and full CPE in the permissible cell lines are
shown in Figure 1A. The infected cell lines exhibited varying
degrees of CPE at different time points and generally, cell lines of
human origin such as HEp-2 exhibited earlier evidence CPE and a
more rapid rate of progression to reach full CPE; by contrast, the
slowest rate of CPE progression was observed in cells of hamster
origin—CHO-K1 (Figure 1B). The first evidence of cell death
(CPE) was observed in HEp-2 cells at 12 hpi, while initial evidence
of CPE in CHO-K1 cells was observed at 48 hpi. The sequential
order in which the five cell lines infected with the same inoculum of
SAFV showing early (10%) CPE was as follows: HEp-2, Neuro2A,
Vero and NIH/3T3, and CHO-K1. The appearance of 100% CPE
was observed in HEp-2 at 48 hpi, whereas full cell death was
observed at 120 hpi in CHO-K1 cells. Progression to full CPE
was also relatively rapid in monkey Vero cells (42 h) when com-
pared to the mouse NIH/3T3 (54 h) cell line. The sequence in
which the five infected cell lines attained full CPE was in the fol-
lowing order: HEp-2, Vero, Neuro2A and NIH/3T3, and CHO-K1.
Neuro2A cells, quite surprisingly, exhibited CPE early after infec-
tion (24 hpi) and had achieved full CPE at 96 hpi. All cell lines
showed 10% CPE between 12 and 48 hpi, 50% CPE between 24 and
72 hpi and 100% CPE between 48 and 120 hpi. Thus, of the cell
lines tested for infection, SAFV was able to infect HEp-2, Vero,
Neuro2A, NIH/3T3 and CHO-K1 and caused different degrees of
cell death at various time points. The SAFV antigen present within
infected cells that had undergone CPE was confirmed by indirect
immunofluorescence assay using commercial cross-reacting pan-
enterovirus monoclonal antibody (Merck Millipore, Billerica, MA,
USA) and anti-SAFV VP1 protein specific rabbit’s polyclonal antibo-
dies prepared in the laboratory. Purified SAFV VP1 proteins for
immunizing rabbits were produced by recombinant DNA technology
using bacterial (Escherichia coli M15) protein expression system and
plasmid vector pQE30 (immunofluorescence assay-positive photo-
graphs and rabbit anti-SAFV VP1 polyclonal antibodies are available
upon request).
SAFV produces a high virus titer in infected cells
The culture supernatants harvested from infected cells were titrated to
assess the productivity of SAFV in these cell lines (Figure 2). Virus
titers of culture supernatants obtained from infected cells reached a
detectable level by 12 hpi for HEp-2, Vero, NIH/3T3 and CHO-K1
and by 24 hpi for Neuro2A. At the time points that virus titers were
detectable, Vero cells attained the highest titer (1.453108 CCID50/mL,
8.16 lgCCID50/mL), followed by HEp-2 (3.16310
7 CCID50/mL,
7.50 lgCCID50/mL), Neuro2A (1.33310
7 CCID50/mL, 7.12 lgCCID50/
mL), CHO-K1 (2.463104 CCID50/mL, 4.39 lgCCID50/mL) and NIH/
3T3 (2.263104 CCID50/mL, 4.35 lgCCID50/mL). Murine NIH/3T3
cells unexpectedly supported efficient virus production, with virus
titers of 3.1631010 CCID50/mL and 10.50 lgCCID50/mL at 72 hpi. At
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the same time point, other cell lines infected by SAFV also attained
high titers: 3.163109 CCID50/mL and 9.50 lgCCID50 mL for HEp-2
and Vero, 2.9031010 CCID50/mL and 9.46 lgCCID50/mL for Neuro2A,
and 2.823108 CCID50/mL and 8.45 lgCCID50/mL for CHO-K1. In
summary, SAFV can achieve high virus titers following infection in
the cells tested.
DNA laddering was observed in all SAFV-infected cells except
HEp-2
To determine the forms of cell death exhibited by the cell lines
following infection with SAFV, DNA was extracted from infected
cells at different time points corresponding to early, mid or full
CPE, and DNA laddering assays were performed (Figure 3A). All
infected cell lines exhibited DNA ‘smearing’ beginning from either
the early or mid CPE time points. Distinct DNA ‘ladder’ patterns
were also observed in all the cell lines except HEp-2. To exclude the
possibility that the cell lines, especially HEp-2 cells, could not
undergo end-stage apoptosis and thus show the ‘laddering’ pattern,
the DNA of each of the respective permissible cell lines was
extracted following treatment with STAU, and the DNA laddering
assay was performed as described above (Figure 3B). The results
showed that all the cell lines treated with STAU, including HEp-
2 cells, were able to undergo the end-stage apoptosis hallmark of
DNA fragmentation by showing a DNA ‘laddering’ pattern.
These results suggest that the infected Vero, Neuro2A, NIH/3T3
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Figure 1 (A) Morphology of the early, mid and full CPEs in SAFV-infected cell lines. Mock-infected cells served as controls for the normal cellular morphology of the
respective cell lines. Magnification:3200. (B) Kinetics of cell death following infection by SAFV. The graph shows the times required for SAFV-infected HEp-2, Vero,
Neuro2A, NIH/3T3 and CHO-K1 cells to attain early (10%), mid (50%) and full (100%) CPEs. The CPE levels of the infected cell lines were assessed by two
independent researchers every 6 h following infection until the cultured cells achieved full CPE. The three points on the graph correspond to the time points at which
the SAFV-infected cell monolayer attained early, mid and full CPE.
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SAFV-infected HEp-2 cells, apoptosis did not proceed to the stage
of DNA fragmentation.
All the SAFV-infected cells exhibited significant caspase-3/7
activity at mid CPE
To confirm the apoptotic activity detected in the DNA laddering
assay, cell lysates of the infected and mock-infected cells harvested at
mid CPE were used to detect the activation of caspase-3 or caspase-
7 using the Apo-ONE fluorometric assay. All the infected cells lines
exhibited significant increases in the levels of caspase-3 or caspase-7
activities in comparison to mock-infected cells (P,0.01) upon
reaching mid CPE (Figure 4). Vero cells exhibited the highest fluor-
escence reading among the five infected cell lines, followed by CHO-
K1, Neuro2A, NIH/3T3 and lastly HEp-2. The fluorescence reading
of HEp-2 cells was the lowest among the five cell lines and was
significantly lower than the fluorescence reading of the NIH/3T3
cell line, which had the next to lowest reading among the infected
cell lines (P,0.05).
SAFV induced apoptosis through both the extrinsic and intrinsic
pathways
To further confirm the apoptotic activity of the SAFV-infected cells
and to determine the apoptotic pathway involved, total proteins from
STAU-treated, mock-infected and SAFV-infected cell lysates har-
vested at mid CPE were subjected to polyacrylamide gel electrophor-
esis andWestern blotting.Membranes were stainedwith the respective
antibodies against caspase-3, -8 and -9 and actin. The intensity of actin
staining served as protein-loading control to ensure that a near-equal
amount of cell lysate from each respective cell linewas loaded into each
well. The cleavage of procaspases-8 and -9 into their activatedmolecu-
lar mass 43 and 37 kDa forms, respectively, was detected in both
STAU-treated and SAFV-infected cell lysates derived from all cell lines
and absent in the mock-infected cell lysates (Figure 5). Cleavage of
procaspase-3 into the 17 kDa active form was also detected in cell
lysates derived from all the STAU-treated and SAFV-infected cell
lines, except in SAFV-infected HEp-2 cells (Figure 5). SAFV induced
apoptosis through both the extrinsic and intrinsic pathways, but
in HEp-2 cells, apoptosis did not proceed to the stage of caspase-3
cleavage.
DISCUSSION
Following the discovery of SAFV, several research groups have attempted
to adapt the virus to grow in various cell lines to study the facets of its
growth kinetics andpathogenesis. Such cells includeWI-38 (lung-derived
human embryonic fibroblasts), HFDK (human fetal diploid kidneys), A-
549 (human lung adenocarcinoma epithelia), BSC (African green mon-
key renal epithelia) and RD (human rhabdomyosarcoma) cells,5 but the
virus could not be recovered from these cells. Zoll et al.3 developed a
method to grow an SAFV-3 isolate from clinical specimens in cultured
cells and performed further studies on the virus as able within the
limitations of this method. Similarly, SAFV-Penang, also belonging to
genotype 3, was first isolated in HEp-2 cells and was shown to pro-
ductively infect a variety of cell lines of primate and rodent origins
following adaptation in Vero cells. Identification of cells that support
productive SAFV infection provides an indication of the virus’s poten-
tial host range and allows phenotypic characterization of infected cells
in vis-a`-vis host–pathogen interactions. However, because SAFV is
recalcitrant to replicate in most cell cultures according to previous
reports, these aspects of virus host cells interactions are not well
studied. Our aim was to provide a platform for further studies of host
cell–SAFV interactions by characterizing some cell lines that could be
productively infected.
Eight cell lines fromAmerican Type Culture Collection were inocu-
lated with SAFV-Penang to determine their potential to support
productive virus growth. Full CPE, as characterized by 100% lysis of
the cell monolayer, was observed in all infected cells with the exception
of the murine kidney (TCMK, CCL-139) and mouse macrophage
(J774A.1, TIB-67 and RAW 264.7, TIB-71) cell lines. Infected cells of
human origin such as HEp-2 exhibited rapid cell death, as full CPE was
achieved within 48 hpi. It was also observed to support efficient virus
replication, with the virus titer reaching 3.163109 CCID50/mL. Vero
cells of monkey origin also supported efficient virus replication and
underwent rapid CPE upon infection. The infected cells exhibited full
CPE within 72 hpi and attained a virus titer of 3.163109 CCID50/mL,
which was as high as that of HEp-2. In this study, SAFV was also found
to be able to productively infect rodent cells, although less efficiently.
This suggests that the virus has the potential to infect other animals,
specifically rodents. A preliminary study in our laboratory, which was
approved by the institutional ethics committee, demonstrated that
SAFV-Penang was able to cause sickness in BALB/c suckling mice
following intracerebral inoculation (unpublished data). The mouse
neuronal cell line, Neuro2A, supported viral replication to nearly the
same extent as human cells, as shown by the fairly similar virus titers at
full CPE. However, the differences in the ability of the virus to induce
CPE in cells, as well as the variation in replication rates, resulting in
differing virus titers, remain unclear, although a recently published
study by Hemida et al.27 demonstrated that variation in virus patho-
genesis may be influenced by the expression of receptor(s) on the host
cells.
A key aspect of the interaction of SAFV with the host cells is its
ability to induce full lysis of the infected cell monolayer. It was
therefore prudent to determine what type of cell death is induced
by SAFV in infected cells. TMEV, a murine cardiovirus that is
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Figure 2 Kinetics of virus growth in SAFV-infected cell lines. Virus titers in culture
supernatants expressed as lgCCID50/mL were determined at various 12-h
intervals (0, 12, 24, 36, 48, 60 and 72 hpi). Virus titers in culture supernatants
were quantified by microneutralization assays using Vero cells. The end point
virus titer was enumerated according to the Reed and Muench method 25 and is
reported as the CCID50. The experiments were performed thrice and the average
values with standard deviations are plotted. CCID50, 50% cell culture infectious
dose.
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induce both apoptosis and necrosis in cultured cells.16 Thus, we
explored the ability of SAFV to induce both apoptosis and necrosis
in infected cell monolayers. DNA fragmentation is a key feature of
end-stage apoptosis and can be visualized through DNA laddering
assays. All infected cells, with the exception of HEp-2, exhibited
both DNA smearing and laddering indicative of necrotic and apop-
totic cell death, respectively. HEp-2 exhibited only smearing even
later into the infection cycle, implying the absence of end-stage
HEp-2
EC MC FC EC MC FC EC MC FC EC MC FC EC MC FCM M M M M
Vero Neuro2A NIH/3T3 CHO-K1
HEp-2
M STAU M STAU M M MSTAU STAU STAU
Vero Neuro2A NIH/3T3 CHO-K1
A
B
Figure 3 DNA laddering analysis to demonstrate end-stage apoptotic cell death. (A) DNA laddering analysis of Saffold virus-infected cell lines at the early, mid
and full CPE time points. The Vero, Neuro2A and CHO-K1 cell lines exhibited DNA ‘smearing’ patterns with early CPE. The NIH/3T3 and HEp-2 cell lines only
showed such patterns from mid CPE onward. The CHO-K1 cell line exhibited the characteristic DNA laddering pattern with early CPE. The Neuro2A and Vero
cell lines showed the DNA laddering pattern beginning at mid CPE and the NIH/3T3 cell line only showed this pattern at full CPE. Infected HEp-2 cells did not
show a DNA laddering pattern. Lanes EC, MC and FC, represent DNA extracted from the SAFV-infected cells showing early, mid and full CPE, respectively.
Lanes marked ‘M’ denote the DNA molecular size marker. (B) DNA laddering analysis of STAU-treated cells as positive controls. All cell lines showed a DNA
laddering pattern when harvested at 4 h following STAU treatment. Lanes marked ‘STAU’ represent DNA extracted after staurosporine treatment. Lanes marked
‘M’ denote the DNA molecular size marker. The experiments were performed in triplicate and one of the three results is presented.
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apoptotic cell death. Moreover, caspase-3 cleavage was also observed
in all cell lines except HEp-2 (Figure 5). The presence of apoptotic
activity induced by SAFV infection was confirmed by the Apo-ONE
fluorometric assay. The levels of caspase-3/7 activation in all cell
lines tested were extremely significantly higher compared to
mock-infected controls, while the levels of caspase-3/7 activation
in HEp-2 were the lowest, which might explain the absence of
DNA laddering and caspase-3 cleavage noted in infected HEp-2 cells
at mid CPE (Figures 3 and 5). This finding suggests that the caspase-3
activation in HEp-2 cells could have been reduced or blocked by an
unknown protein, thus preventing the cleavage product from reaching
a sufficient level to subsequently cause the cells to undergo end-stage
apoptosis.
There are two main mechanisms through which apoptosis is
induced in cells, namely, the extrinsic and intrinsic pathways. The
Western blot data showed the cleavage of procaspase-8 and procas-
pase-9 into their respective molecular mass 43 and 37 kDa forms in
all cell lines infected by SAFV-Penang, implying that activation of
apoptosis occurred through both the intrinsic and extrinsic pathways.
Procaspase-3 is the final executor in the apoptotic signaling cascade
and is responsible for chromatin cleavage and DNA laddering. Its
cleavage into its active molecular mass 17 kDa form was also
observed in all cell lines except HEp-2. The infection of HEp-2 cells
with SAFV-Penang led to the activation of both the intrinsic and
extrinsic pathways, but failed to progress further into the full activa-
tion of caspase-3 and resultant DNA laddering. The molecule(s)
responsible for blocking the progression into the late stages of apop-
tosis in HEp-2 cells are not known and are under investigation in our
laboratory. Recently, Fanet et al.28 determined that transfection of the
TMEV Leader protein into BHK-21 cells resulted in the induction of
apoptosis between 24 and 48 h post-transfection via the intrinsic
pathway.28 Whether SAFV Leader peptide can induce apoptosis in a
manner similar to the L protein of TMEV would be an interesting
subject of inquiry and is also currently under investigation in our
laboratory. Further characterization of the key host cell and viral
proteins involved in the dynamics of host cell–pathogen interactions
and that have either pro-apoptotic or anti-apoptotic activities in res-
ponse to SAFV infection would also be an interesting area of inves-
tigation.
In conclusion, SAFV-Penang can infect a number of primate and
rodent cell lines, including HEp-2, Vero, Neuro2A, NIH/3T3 and
CHO-K1, and induce the host cells to undergo apoptosis through both
the extrinsic and intrinsic pathways. However, the late stage apoptotic
activities of HEp-2 cells are blocked. In future studies, we will focus on
determining the viral protein(s) causing apoptosis and themechanism




































Figure 4 Apo-ONE Fluorometric assay of SAFV-infected HEp-2, Vero,
Neuro2A, NIH/3T3 and CHO-K1 cell lines harvested at mid CPE in compa-
rison with mock-infected cells. A paired Student’s t-test was used to compare
the fluorometric readings, and differences were considered significant
at *P,0.05 and extremely significant at **P,0.01. All experiments were















Vero Neuro2A NIH/3T3 CHO-K1
Figure 5 Western blots of cell lysates derived from SAFV-infected HEp-2, Vero, Neuro2A, NIH/3T3 and CHO-K1 cell lines harvested at mid CPE in comparison
with respective mock-infected control and STAU-treated control cells. Membranes were stained with respective antibodies against caspases-3, -8, -9 and actin.
The intensity of actin staining served as the protein loading control. Lanes with I denote infected cell lysates, lanes with MI denote mock-infected control cell
lysates, lanes with STAU denote STAU-treated control cell lysates and lanes with MW indicate the protein molecular mass in kDa. Caspases-3, -8 and -9 were
cleaved to their respective active forms (p17, p43 and p37) in SAFV-infected Vero, Neuro2A, NIH/3T3, CHO-K1 cells and all STAU-treated cells. Only caspases-
8 and -9 were cleaved to their active forms in SAFV-infected HEp-2 cells. The Western blotting results shown here are representative one of the three replicate
experiments.
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